Latest stories
AI Scientific Temper Can Challenge Healthcare Superstitions in India
Generic
Old customs and superstitions still prevail in India and continue to hold back the world’s second most populous nation from enjoying the full fruits of modernization. Disha Ganguli believes the government can rid the country of these old beliefs if it utilizes artificial intelligence to introduce a scientific temper.
Disha Ganguli  |  Jan 06 , 2022
Women in AI Switzerland: Looking Back, Moving Forward
Optimization
The Women in AI community in Switzerland, like most, have experienced a challenging year. The pandemic took its toll on the team, and on the health of their families and friends. Marisa Tschopp takes a look back on a difficult year and looks forward to a brighter future in 2022.
Marisa Tschopp  |  Jan 05 , 2022
AI vs COVID-19 and Why This Matters
Pandemic
Scott Campbell maps out four reasons why artificial intelligence failed pandemic planners and offers a three-point future prevention strategy.
Scott Campbell  |  Jan 04 , 2022
The Future of AI in Medicine: To Boldly Go Where No Man Has Gone Before
New Era
Artificial intelligence is no longer part of a nonsensical plot line in a sci-fi TV series like Star Trek. It is a driver of innovation and change in every aspect of life, especially in the medical sector. Prof Bradley J. Erickson maps out how healthcare will look in five years’ time.
Bradley J. Erickson  |  Jan 03 , 2022
The Yuan AI 2022 - Big Pharma, Big Tech Ally, Double-Team COVID-19
Emerging Market
The alliance of Big Pharma and Big Tech in the mostly successful quest to develop vaccines to defeat COVID-19 has been one of the most noteworthy events of this year. In the last of the series of articles this week on The Yuan platform predicting the evolution of artificial intelligence in 2022, Ben Armour explores how this marriage has transfigured healthcare, as well as reaping a windfall for both sectors, and forecasts what this union holds in store for 2022.
Ben Armour  |  Dec 31 , 2021
The Yuan AI 2022 - Trends Prognosis Very Healthy Indeed
Optimization
The Yuan contributor Kirk Borne presents the fourth article this week on The Yuan platform predicting the evolution of artificial intelligence in 2022. He predicts another year of growing macro trends in the global AI sphere which will open many new ways of thinking, surprising innovations, and more stable solutions to critical problems.
Kirk Borne  |  Dec 30 , 2021
The Yuan AI 2022 - Better Data Better Healthcare
Domain Knowledge
Gil Press presents the third in a series of articles this week on The Yuan platform predicting the evolution of artificial intelligence in 2022. He acknowledges it is difficult to predict the future of science, industry, and healthcare, but believes data, data, and even more data, will play a central role in shaping it in 2022.
Gil Press  |  Dec 29 , 2021
The Yuan AI 2022 - To Infinity and Beyond
New Era
Dr Gaurav Chandra presents the second in a series of articles this week on The Yuan platform predicting the evolution of artificial intelligence in 2022. He looks forward to what the future holds for us next year and explores five trends in AI that will shape humankind forever.
Gaurav Chandra  |  Dec 28 , 2021
The Yuan AI 2022 - Evolution Opens Door to Longevity
New Era
Calum Chace presents the first in a series of articles this week on The Yuan platform predicting the evolution of AI in 2022. The best-selling author predicts in the tenth anniversary year of the Big Bang in artificial intelligence we will see better drug discovery processes, better diagnostics, and better understanding of human biology.
Calum Chace  |  Dec 27 , 2021
What do we Know About Omicron?
Pandemic
Omicron is a new variant of the virus that causes COVID-19, but what do we know about it? Anna Meisiana provides some background and updates on the new coronavirus strain that has rocked the world.
Anna Meisiana  |  Dec 24 , 2021
Community More+
Calum Chace
Calum Chace
Calum Chace is a keynote speaker and best-selling writer on AI. He focuses on the medium- and long-term impact of AI on all of us, our societies and our economies. He is the author of ‘Surviving AI,’ about strong AI and superintelligence.
Lenny Mendonca
Lenny Mendonca
Lenny Mendonca, Senior Partner Emeritus at McKinsey & Company, is a former chief economic and business adviser to Governor Gavin Newsom of California and chair of the California High-Speed Rail Authority.
Laura Tyson
Laura Tyson
Laura Tyson, former chair of the US President’s Council of Economic Advisers, is Professor of the Graduate School at the Haas School of Business and Chair of the Blum Center Board of Trustees at the University of California, Berkeley.
Emmanuel Fombu
Emmanuel Fombu
Emmanuel Fombu is a physician with a particular interest in the future of healthcare. Among his many accomplishments, he also holds a certification in AI: Implications for Business Strategy from MIT’s Sloan School of Management and Computer Science AI Lab.
Evelyne Bischof
Evelyne Bischof
Evelyne Bischof is chief physician associate of internal medicine at University Hospital Renji of Jiaotong University Shanghai and an executive at the Longevity Science Foundation. Her research focus is oncology and longevity medicine, AI and digital health, precision medicine, biogerontology and geronto-oncology.
Nicolas Ibanez
Nicolas Ibanez
Nicolas Ibanez is a physical therapist with a specialty in osteopathy and a passion for Digital Health Solutions. He has extensive experience in digital health solutions and is founder of Nuve, a health food franchise, EasyMD, a telehealth startup and Fisiomed, Nicaragua’s first sports medical clinic.
Reza Jarral
Reza Jarral
Reza Jarral is a physician, Edmund Hillary Fellow and a 'AI4Health' advisor at the World Health Organisation. Prior to joining CareHQ as the clinical director for virtual health, Reza worked alongside marginalised communities for over a decade, delivering care at the front line in the NHS, New Zealand and sub-Saharan Africa.
Verena Voelter
Verena Voelter
Verena Voelter is the founder and managing director of 5P Health Care Solutions, a consulting firm that supports the cocreation of innovative solutions for a modern value-based health care system. She is author of ‘It Takes 5 to Tango – From Competition to Cooperation in Health Care.’
Ikechukwu Enyeribe Anyanwu
Ikechukwu Enyeribe Anyanwu
Ikechukwu Enyeribe Anyanwu is a physician with over eight years of experience in clinical and hospital management. His interests span across global health management, healthcare quality improvement, digital health transformation and the strategic application of artificial intelligence in healthcare.
Gaurav Chandra
Gaurav Chandra
Gaurav Chandra is the Chief Operating Officer of Enzolytics, a drug development company. He also runs a platform that uses AI to assess the effects of nutrition, genetics and gut microbiome on chronic medical diseases and infectious diseases. He is a strong proponent of AI's role in early drug discovery and development.